Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3
Failed dissolution specifications.
| Recalling firm | Apotex Corp. |
|---|---|
| Reason | Failed dissolution specifications. |
| Risk class | Class II (Class II · moderate) |
| Status | Ongoing |
| Report date | Oct 7, 2026 |
| Initiated | Sep 23, 2026 |
| Region | FL, United States |
| Distribution | US Nationwide. |
| Code/Lot | Lot# TY9495, Exp Date: 05/2027. |
| Type | Voluntary: Firm initiated |
| Recall number | D-0877-2026 |
Official source
U.S. FDA — Recalls, Market Withdrawals & Safety Alerts fda.gov ↗You can re-verify each item on the official FDA site using its recall number. (Recall number: D-0877-2026)
openFDA (U.S. Food & Drug Administration) — food/drug/device enforcement · CC0 1.0 (public domain)
Find out more
- Search this recall on FDA fda.gov ↗
- Search related news (Google News) news.google.com ↗
- Search this product (Google) google.com ↗
The links above open external searches by recall number / product name; the results are the responsibility of each site.
This page summarizes U.S. FDA data for general information and is not medical advice. Confirm details via official FDA announcements and the manufacturer.